Cite
Real-world outcomes in 2646 psoriasis patients: one in five has PASI ≥10 and/or DLQI ≥10 under ongoing systemic therapy.
MLA
Norlin, J. M., et al. “Real-World Outcomes in 2646 Psoriasis Patients: One in Five Has PASI ≥10 and/or DLQI ≥10 under Ongoing Systemic Therapy.” Journal of Dermatological Treatment, vol. 28, no. 6, Sept. 2017, pp. 500–04. EBSCOhost, https://doi.org/10.1080/09546634.2017.1289147.
APA
Norlin, J. M., Calara, P. S., Persson, U., & Schmitt-Egenolf, M. (2017). Real-world outcomes in 2646 psoriasis patients: one in five has PASI ≥10 and/or DLQI ≥10 under ongoing systemic therapy. Journal of Dermatological Treatment, 28(6), 500–504. https://doi.org/10.1080/09546634.2017.1289147
Chicago
Norlin, J. M., P. S. Calara, U. Persson, and M. Schmitt-Egenolf. 2017. “Real-World Outcomes in 2646 Psoriasis Patients: One in Five Has PASI ≥10 and/or DLQI ≥10 under Ongoing Systemic Therapy.” Journal of Dermatological Treatment 28 (6): 500–504. doi:10.1080/09546634.2017.1289147.